SCHEMBL21035628

SCHEMBL21035628

C[C@@H](c1ccc(-c2ccc(Cl)cc2)cc1)N1CCN(S(=O)(=O)c2ccc(OCC3CCCCC3)cc2)[C@H](C(=O)N2CCC(NC(=O)OC(C)(C)C)CC2)C1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
ACACB O00763 2/20 0.39
MMP13 P45452 7/20 0.37
MMP1 P03956 6/20 0.37
ADAM17 P78536 3/20 0.37
CCR4 P51679 1/20 0.36
MMP9 P14780 4/20 0.36
ALOX5 P09917 1/20 0.36
EPHX2 P34913 1/20 0.36
ITGB1 P05556 1/20 0.36
ITGA4 P13612 1/20 0.36
MMP3 P08254 2/20 0.35
MMP7 P09237 2/20 0.35
CHRM2 P08172 1/20 0.35
CHRM1 P11229 1/20 0.35
GHSR Q92847 2/20 0.35
NPSR1 Q6W5P4 1/20 0.35
GPR119 Q8TDV5 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21035598 0.88 MMP1 (0.43) KMT2AMEN1MMP13MMP1ADAM17
SCHEMBL21035070 0.88 MMP1 (0.43) KMT2AMEN1MMP13MMP1ADAM17
SCHEMBL21035340 0.88 MEN1 (0.41) KMT2AMEN1MMP13MMP1ADAM17
SCHEMBL21035600 0.88 MEN1 (0.41) KMT2AMEN1MMP13MMP1ADAM17
SCHEMBL21035442 0.88 MEN1 (0.41) KMT2AMEN1MMP13MMP1ADAM17
SCHEMBL21035633 0.87 GHSR (0.45) KMT2AMEN1MMP13MMP1MMP9
SCHEMBL21001945 0.87 GHSR (0.45) KMT2AMEN1MMP13MMP1MMP9
SCHEMBL21002001 0.87 GHSR (0.45) KMT2AMEN1MMP13MMP1MMP9
SCHEMBL21035635 0.86 ACACB (0.38) ACACBMMP13MMP1ADAM17CCR4
SCHEMBL21035321 0.84 ACACB (0.39) ACACBMMP13MMP1ADAM17MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019104011-A1 CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE BIOMARIN PHARMACEUTICAL INC. (US) 2019-05-31 WO disclosed